Scott B. Brown is CHIEF FINANCIAL OFFICER of Tracon Pharmaceuticals, Inc.. Currently has a direct ownership of 25,128 shares of TCON, which is worth approximately $753. The most recent transaction as insider was on Apr 20, 2023, when has been sold 3,500 shares (Common Stock) at a price of $0.14 per share, resulting in proceeds of $490. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.1K
0% 3M change
0% 12M change
Total Value Held $753

Scott B. Brown Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 20 2023
BUY
Grant, award, or other acquisition
$490 $0.14 p/Share
3,500 Added 12.23%
25,128 Common Stock
Dec 29 2022
BUY
Open market or private purchase
$5,215 $1.49 p/Share
3,500 Added 13.93%
21,628 Common Stock
Sep 12 2022
BUY
Open market or private purchase
$5,050 $2.02 p/Share
2,500 Added 14.6%
14,628 Common Stock
Mar 29 2022
BUY
Open market or private purchase
$2,820 $2.82 p/Share
1,000 Added 10.39%
8,628 Common Stock
Aug 13 2021
BUY
Open market or private purchase
$3,690 $3.69 p/Share
1,000 Added 11.59%
7,628 Common Stock
Mar 08 2021
BUY
Open market or private purchase
$8,300 $8.3 p/Share
1,000 Added 24.22%
3,128 Common Stock
SBB

Scott B. Brown

CHIEF FINANCIAL OFFICER
San Diego, CA

Track Institutional and Insider Activities on TCON

Follow Tracon Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TCON shares.

Notify only if

Insider Trading

Get notified when an Tracon Pharmaceuticals, Inc. insider buys or sells TCON shares.

Notify only if

News

Receive news related to Tracon Pharmaceuticals, Inc.

Track Activities on TCON